Hyphens Pharma International Ltd
SGX:1J5
Wall Street
Price Targets
1J5 Price Targets Summary
Hyphens Pharma International Ltd
According to Wall Street analysts, the average 1-year price target for 1J5 is 0.36 SGD with a low forecast of 0.35 SGD and a high forecast of 0.37 SGD.
Operating Income
Forecast
Operating Income Estimate
Hyphens Pharma International Ltd
For the last 8 years the compound annual growth rate for Hyphens Pharma International Ltd's operating income is 10%. The projected CAGR for the next 3 years is 2%.
Net Income
Forecast
Net Income Estimate
Hyphens Pharma International Ltd
For the last 8 years the compound annual growth rate for Hyphens Pharma International Ltd's net income is 9%. The projected CAGR for the next 3 years is 6%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 1J5's stock price target?
Price Target
0.36
SGD
According to Wall Street analysts, the average 1-year price target for 1J5 is 0.36 SGD with a low forecast of 0.35 SGD and a high forecast of 0.37 SGD.
What is Hyphens Pharma International Ltd's Revenue forecast?
Projected CAGR
4%
For the last 8 years the compound annual growth rate for Hyphens Pharma International Ltd's revenue is 9%. The projected CAGR for the next 3 years is 4%.
What is Hyphens Pharma International Ltd's Operating Income forecast?
Projected CAGR
2%
For the last 8 years the compound annual growth rate for Hyphens Pharma International Ltd's operating income is 10%. The projected CAGR for the next 3 years is 2%.
What is Hyphens Pharma International Ltd's Net Income forecast?
Projected CAGR
6%
For the last 8 years the compound annual growth rate for Hyphens Pharma International Ltd's net income is 9%. The projected CAGR for the next 3 years is 6%.
You don't have any saved screeners yet
